We could not discern a clear trend regarding whether using data from clinical trials instead of observational studies in terms of baseline risk and treatment effect improves the cost-effectiveness results.
← all excerpts
Cost-effectiveness of Ezetimibe plus statin lipid-lowering therapy: A systematic review and meta-analysis of cost-utility studies.
1
—
—